Faruqi and Faruqui, LLP Logo
Share this page

Fresenius Medical Care AG & Co. KGAA (FMS)



Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Fresenius Medical Care AG & Co. KGAA To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Fresenius Medical Care AG & Co. KGAA (“Fresenius Medical” or the “Company”) (NYSE:FMS).

The investigation focuses on whether the Company and its executives violated federal securities laws.

Specifically, after market close on January 6, 2017, the Wall Street Journal published an article disclosing that Fresenius Medical’s North American subsidiary received a subpoena seeking “information about our interactions” relating to the Company’s ties to the American Kidney Fund, a charity that helps patients pay for kidney dialysis. On this news, the price of the Company’s American Depositary Receipt (“ADR”) was negatively affected, causing investors harm.

Take Action

If you invested in Fresenius Medical ADRs and would like to discuss your legal rights, please fill out the form below.  You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Fresenius Medical’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Request Information

Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you.

  • Case:
    Fresenius Medical Care AG & Co. KGAA (FMS)

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330


Case Details


  • 01/26/2017

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.